Inventor · disambiguated record
Terrence Lee Fisher
Also filed as: FISHER JR TERRENCE L · FISHER JR TERRENCE LEE · FISHER TERRENCE · FISHER TERRENCE L
10 granted patents·4 pending applications·174 citations·filing 2002–2023
90Inventor score
Top patents by PatentIndex Score
14 records- 0196US8496938B2Anti-CD100 neutralizing neutralizing antibodies and methods of using the sameSMITH ERNEST S·Filed 2010·Granted Jul 30, 2013·40 cites·19 claims
- 0296US7919594B2Human anti-CD100 antibodiesVACCINEX INC·Filed 2008·Granted Apr 5, 2011·55 cites·36 claims
- 0394US9090709B2Anti-SEMA4D antibodies and epitopesVACCINEX INC·Filed 2013·Granted Jul 28, 2015·18 cites·7 claims
- 0494US8816058B2Polynucleotides encoding anti-CD100 antibodies or antigen-binding fragments thereofSMITH ERNEST S·Filed 2012·Granted Aug 26, 2014·24 cites·24 claims
- 0592US9605055B2Anti-CD100 antibodies and methods of using the sameVACCINEX INC·Filed 2013·Granted Mar 28, 2017·14 cites·11 claims
- 0691US9676840B2Anti-CD100 neutralizing antibodies and methods of using the sameVACCINEX INC·Filed 2013·Granted Jun 13, 2017·11 cites·28 claims
- 0785US10301393B2Methods of treating multiple sclerosis using anti-CD20 antibodiesVACCINEX INC·Filed 2016·Granted May 28, 2019·4 cites·6 claims
- 0885US9382327B2Anti-CD20 antibodies and methods of useSMITH ERNEST S·Filed 2007·Granted Jul 5, 2016·8 cites·9 claims
- 0981US12006364B2Anti-CD100 antibodies and methods for using the sameVACCINEX INC·Filed 2022·Granted Jun 11, 2024·0 cites·13 claims
- 1070US11274149B2Anti-CD100 antibodies and methods for using the sameVACCINEX INC·Filed 2017·Granted Mar 15, 2022·0 cites·13 claims
- 1161US2023101618A1Predictive outcome profiling for use of an anti-semaphorin-4d binding molecule to treat neurodegenerative disordersVACCINEX INC·Filed 2022·Application pending·0 cites
- 1260US2023331863A1Combination therapy with semaphorin-4d blockade and htt-lowering agent for treatment of huntington's diseaseVACCINEX INC·Filed 2023·Application pending·0 cites
- 1350US2020317788A1Semaphorin-4d antagonists for use in cancer therapyVACCINEX INC·Filed 2020·Application pending·0 cites
- 1446US2004219163A1Human glandular kallikrein (hk2)-specific monoclonal antibodies that enhance or inhibit the enzymatic activity of hk2Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Terrence Lee Fisher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →